Analysts at Needham downgraded EnerNOC, Inc. (ENOC) from ‘Strong‘ to ‘Buy‘ in a research report issued to clients on Friday.
The target price for ENOC is lowered from $25 to $18.50.
On valuation measures, EnerNOC Inc. stock it is trading at a forward P/E multiple of 31.22x, and at a multiple of 21.20x this year’s estimated earnings. The t-12-month revenue at EnerNOC Inc. is $461.97 million. ENOC ‘s ROE for the same period is 6.33%.
Shares of the $376.83 million market cap company are down 13.23% year-over-year ; up 18.83% year-to-date.
EnerNOC, Inc., currently with a median Wall Street price target of $26.00 and a high target of $28.00, dropped $4.39 to $13.9695 in recent trading.
The chart below shows where the equity has traded over the past 52-weeks.
Seadrill Partners LLC (SDLP) was downgraded from ‘Outperform‘ to ‘Sector Perform‘ and the price target was cut from $20 to $17 at RBC Capital Markets.
Shares have traded today between $15.21 and $15.93 with the price of the stock fluctuating between $13.00 to $36.07 over the last 52 weeks.
Seadrill Partners LLC shares are currently changing hands at 7.79x this year’s forecasted earnings, compared to the industry’s 11.94x earnings multiple. Ticker has a t-12 price/sales ratio of 1.22. EPS for the same period registers at $1.99.
Shares of SDLP have lost $0.60 to $15.50 in mid-day trading on Friday, giving it a market cap of roughly $1.42 billion. The stock traded as high as $36.07 in July 21, 2014.
Credit Suisse (CS) reported on Friday that they have lowered their rating for Safe Bulkers, Inc. (SB) from ‘Outperform‘ to ‘Neutral‘.
Safe Bulkers Inc. recently traded at $3.58, a loss of $0.15 over Thursday’s closing price. The name has a current market capitalization of $298.75 million.
As for passive income investors, the company pays shareholders $0.16 per share annually in dividends, yielding 4.60%. Five year average dividend yield currently stands at 6.40%.
Allscripts Healthcare Solutions, Inc (MDRX) had its rating lowered from ‘Outperform‘ to ‘Market Perform‘ by analysts at Leerink Partners on Friday. Currently there are 9 analysts that rate MDRX a ‘Buy’, 1 analyst rates it a ‘Sell’, and 15 rate it a ‘Hold’.
MDRX was down $0.85 at $11.90 in mid-day trade, moving within a 52-week range of $11.00 to $19.68. The name, valued at $2.15B, opened at $12.05.
On valuation measures, Allscripts Healthcare Solutions Inc. shares currently trade at a forward P/E of 19.83x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 1.66 and EPS for the same period of ($0.48).
Insulet Corporation (PODD) was downgraded by Oppenheimer from a ‘Outperform‘ rating to a ‘Perform‘ rating in a research report issued to clients on Friday. They currently have a $33 price objective on the stock, six points lower from their previous price target of $39.
PODD closed at $32.91 on Thursday and is currently trading down $2.05.
In the past 52 weeks, shares of the company have traded between a low of $27.02 and a high of $51.31 and are now trading at $30.86. Shares are down 28.13% year-over-year and 28.55% year-to-date.